Published in Gene Therapy Weekly, August 19th, 2004
From April-June 2004, 60 cancer patients were successfully treated in procedures that produced a number of patient benefits including significantly reduced surgical times and reduced blood loss. The trials were conducted under the auspices of the company's subsidiary, Live Tissue Connect.
The trial procedures included:
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.